Journal of Neuro-Oncology 2005-07-01

Meningiomas expressing and responding to cholecystokinin (CCK).

Eftychia Oikonomou, Ana L Machado, Michael Buchfelder, Eric F Adams

Index: J. Neurooncol. 73(3) , 199-204, (2005)

Full Text: HTML

Abstract

The effect of cholecystokinin (CCK) on cultured human meningioma derived cells was investigated. Exposure of meningioma cells for 6-12 days to CCK-8s (2-200 nM) resulted in a dose dependent stimulation of cell growth to a maximum of 1.1-fold over basal controls. A time course study showed stimulation of cell growth at day 3 followed by increase throughout day 6. The stimulatory effect of CCK on meningioma cell growth was completely abolished by a CCK-B specific receptor antagonist, L-365,260. Reverse-transcription of meningioma-derived RNA into cDNA followed by amplification by the polymerase chain reaction using specific primers for CCK peptide and its CCK-A and/B receptor revealed 100% presence of CCK peptide and CCK-B receptors mRNA whereas CCK-A receptor was expressed in 66% of the meningiomas. These results provide evidence that human meningioma cells possess CCK peptide and its receptors the activation of which leads to increase of cell growth possibly via an autocrine/paracrine mechanism.

Related Compounds

  • L-365,260

Related Articles:

Combination pharmacotherapy for the treatment of neuropathic pain in adults.

2012-01-01

[Cochrane Database Syst. Rev. 7 , CD008943, (2012)]

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

2005-01-13

[J. Med. Chem. 48(1) , 180-91, (2005)]

A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

2008-07-01

[Br. J. Pharmacol. 154(5) , 1009-15, (2008)]

Cholecystokinin action on layer 6b neurons in somatosensory cortex.

2009-07-28

[Brain Res. 1282 , 10-9, (2009)]

CCK(B) receptor antagonist L365,260 potentiates the efficacy to and reverses chronic tolerance to electroacupuncture-induced analgesia in mice.

2007-03-15

[Brain Res. Bull. 71(5) , 447-51, (2007)]

More Articles...